ReviewHeart rhythm O22025
Veterans health administration national cardiac device surveillance program: Structured, centralized remote monitoring for cardiovascular implantable electronic devices to improve quality of care.
Review in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Congenital heart diseases involving congenitally diseased pulmonary valve phenotypes: Novel insights into the health care burden across the life course.JTCVS open · 2026Article
- Outcomes associated with remote monitoring without in-person evaluations for patients with cardiovascular implantable electronic devices.Heart rhythm O2 · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Remote monitoring (RM) is central to care of patients with cardiovascular implantable electronic devices (CIEDs). However, because RM care presents a large and increasing clinician workload, solutions are needed to increase care efficiency. The Veterans Health Administration National Cardiac Device Surveillance Program (VHANCDSP) is a response to this need by centralizing RM processes, reviewing all RM transmissions, identifying patients affected by recalls, and providing guidance on clinical response for 122 VHA CIED clinics across the United States and Puerto Rico. The VHANCDSP promotes participation and adherence in RM, ensuring evidence-based care. The centralized infrastructure also positions the VHANCDSP to evaluate and implement quality improvement interventions, ultimately enhancing clinical care for patients with CIEDs. This article describes and reflects on this infrastructure and provides specific recommendations about how high-quality RM care can be provided in care other health care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.